CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa.
Nolan ND, Cui X, Robbings BM, Demirkol A, Pandey K, Wu WH, Hu HF, Jenny LA, Lin CS, Hass DT, et al. Cell Rep Med. 2024 Apr 16; 5(4):101459. Epub 2024 Mar 21.